Testing effectiveness (Phase 2)WithdrawnNCT00963664What this trial is testingEvaluation of Interferon-Lovastatin Therapy for Malignant MelanomaWho this might be right forMelanomaMalignant Melanoma NeoPlas Innovation 250
Early research (Phase 1)Study completedNCT01846143What this trial is testingEvaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced MalignanciesWho this might be right forMelanoma Craig L Slingluff, Jr 15
Not applicableLooking for participantsNCT07524114What this trial is testingStudy of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)Who this might be right forBreast CancerLung CancerMelanoma+7 more University Health Network, Toronto 7,000
Early research (Phase 1)Looking for participantsNCT06270706What this trial is testingPLN-101095 in Adults With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumor Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Ended earlyNCT02709889What this trial is testingRovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid TumorsWho this might be right forMalignant MelanomaMedullary Thyroid CancerGlioblastoma+5 more AbbVie 200
Testing effectiveness (Phase 2)Study completedNCT00085423What this trial is testingCyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Dartmouth-Hitchcock Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00665470What this trial is testingChemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat MelanomaWho this might be right forSkin CancerMetastatic Melanoma National Cancer Institute (NCI) 10
Post-approval studies (Phase 4)Ended earlyNCT01683188What this trial is testingHD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic MelanomaWho this might be right forMetastatic Melanoma Clinigen, Inc. 53
Not applicableStudy completedNCT03080948What this trial is testingRisk Stratification Among Individuals Who Have Many Moles on Their SkinWho this might be right forHigh-Risk Nevus Phenotype Memorial Sloan Kettering Cancer Center 73
Not applicableLooking for participantsNCT07680699What this trial is testingNEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II MelanomaWho this might be right forCutaneous Melanoma AC Camargo Cancer Center 250
Early research (Phase 1)Study completedNCT01943422What this trial is testingSafety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in MelanomaWho this might be right forMelanoma John Kirkwood 7
Large-scale testing (Phase 3)Looking for participantsNCT05770102What this trial is testingDETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) DispositionWho this might be right forMalignancyMalignant NeoplasmLymphoproliferative Disorders+7 more Cancer Research UK 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06521567What this trial is testingCobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerWho this might be right forMelanomaHodgkin LymphomaHigh and Low Grade Glioma+9 more GlaxoSmithKline 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT00539591What this trial is testingPhase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk MelanomaWho this might be right forMalignant Melanoma St. Jude Children's Research Hospital 29
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Early research (Phase 1)Study completedNCT03236935What this trial is testingPhase Ib of L-NMMA and PembrolizumabWho this might be right forNon-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more The Methodist Hospital Research Institute 12
Not applicableNot Yet RecruitingNCT07437300What this trial is testingInfluence of a High-fiber Diet on the Microbiota and the Response to Immunotherapy in Patients Treated for Melanoma.Who this might be right forMelanoma University Hospital, Grenoble 60
Not applicableStudy completedNCT01460875What this trial is testingRecombinant Interferon Alfa-2b in Treating Patients With MelanomaWho this might be right forStage IA Skin MelanomaStage IB Skin MelanomaStage IIA Skin Melanoma+6 more William Carson 34